Zkusit zdarma
Artivion, Inc.

Artivion, Inc.

AORT
Cena:
 
 
Valuace
8
Růst
48
Zdraví
61
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

8:00 18-05-2026

Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that A...

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

7:05 18-05-2026

HERZLIYA, Israel--(BUSINESS WIRE)-- #aortaEd--Endospan, a pioneer in endovascular solutions for comp...

Artivion Completes Acquisition of Endospan Ltd.

Artivion Completes Acquisition of Endospan Ltd.

7:00 18-05-2026

ATLANTA, May 18, 2026 Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company fo...

Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding

Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding

16:31 17-05-2026

Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide t...

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.

11:30 11-05-2026

MILWAUKEE, May 11, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims...

Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript

Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript

15:07 10-05-2026

Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript...

Artivion Q1 Earnings Call Highlights

Artivion Q1 Earnings Call Highlights

7:06 09-05-2026

Artivion NYSE: AORT executives said the company delivered double-digit revenue and adjusted EBITDA g...

Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates

Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates

20:11 07-05-2026

Artivion (AORT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Est...

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

16:05 07-05-2026

First Quarter & Recent Business Highlights: Achieved revenue of $116.3 million in the first quarter ...

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

16:15 23-04-2026

ATLANTA, April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular ...

Artivion Secures FDA Approval for NEXUS Aortic Arch System

Artivion Secures FDA Approval for NEXUS Aortic Arch System

11:35 08-04-2026

AORT jumps after FDA approves NEXUS Aortic Arch System, unlocking a potential Endospan acquisition a...

Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?

Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?

4:47 08-04-2026

Artivion (AORT) witnessed a jump in share price last session on above-average trading volume. The la...

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

7:00 07-04-2026

Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch dis...

SG Americas Securities LLC Raises Stake in Artivion, Inc. $AORT

SG Americas Securities LLC Raises Stake in Artivion, Inc. $AORT

5:03 06-04-2026

SG Americas Securities LLC boosted its position in shares of Artivion, Inc. (NYSE: AORT) by 578.4% i...

Artivion (NYSE:AORT) Shares Gap Down – Should You Sell?

Artivion (NYSE:AORT) Shares Gap Down – Should You Sell?

3:49 04-04-2026

Artivion, Inc. (NYSE: AORT - Get Free Report)'s stock price gapped down prior to trading on Thursday...

Artivion, Inc. (NYSE:AORT) Receives Consensus Rating of “Moderate Buy” from Analysts

Artivion, Inc. (NYSE:AORT) Receives Consensus Rating of “Moderate Buy” from Analysts

4:24 28-03-2026

Shares of Artivion, Inc. (NYSE: AORT - Get Free Report) have received an average rating of "Moderate...

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

16:10 03-03-2026

ATLANTA, March 3, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular ...

Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript

Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript

23:04 12-02-2026

Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript...

Artivion (AORT) Q4 Earnings Surpass Estimates

Artivion (AORT) Q4 Earnings Surpass Estimates

18:31 12-02-2026

Artivion (AORT) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Est...

Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

16:05 12-02-2026

Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97....

close

ARTIVION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

12-02-2026
FOURTH QUARTER HIGHLIGHTS: GAAP REVENUE WAS $116.0 MILLION IN THE FOURTH QUARTER OF 2025 VERSUS $97....
Více zde

ARTIVION ANNOUNCES PRESENTATION OF POSITIVE NEW CLINICAL DATA FROM NEXUS TRIOMPHE AND AMDS PERSEVERE TRIALS AT THE 62ND SOCIETY OF THORACIC SURGERY ANNUAL MEETING

02-02-2026
1-YEAR DATA FROM ENDOSPAN'S NEXUS TRIOMPHE IDE TRIAL DEMONSTRATE HIGH PATIENT SURVIVAL WITH LOW MORB...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR FOURTH QUARTER 2025 FINANCIAL RESULTS

29-01-2026
ATLANTA, JAN. 29, 2026 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

06-11-2025
THIRD QUARTER HIGHLIGHTS: ACHIEVED REVENUE OF $113.4 MILLION IN THE THIRD QUARTER OF 2025 VERSUS $95...
Více zde

ARTIVION ANNOUNCES TREATMENT OF FIRST PATIENT WITH ARCEVO LSA IN ARTIZEN PIVOTAL TRIAL

06-11-2025
ATLANTA , NOV. 6, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

ARTIVION TO PARTICIPATE IN THE STIFEL 2025 HEALTHCARE CONFERENCE

29-10-2025
ATLANTA , OCT. 29, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR THIRD QUARTER 2025 FINANCIAL RESULTS

23-10-2025
ATLANTA , OCT. 23, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION ANNOUNCES PRESENTATION OF LATE-BREAKING DATA FROM AMDS PERSEVERE AND AMDS PROTECT TRIALS AT THE 39TH EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) ANNUAL MEETING

13-10-2025
30-DAY DATA FROM THE AMDS PERSEVERE TRIAL DEMONSTRATES VISCERAL MALPERFUSION RESOLUTION IN 83%, AND ...
Více zde

ARTIVION TO PARTICIPATE IN MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

05-09-2025
ATLANTA , SEPT. 5, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

07-08-2025
SECOND QUARTER HIGHLIGHTS: ACHIEVED REVENUE OF $113.0 MILLION IN THE SECOND QUARTER OF 2025 VERSUS $...
Více zde

ARTIVION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

30-07-2025
ATLANTA , JULY 30, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR SECOND QUARTER 2025 FINANCIAL RESULTS

24-07-2025
ATLANTA , JULY 24, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

DATA BREACH ALERT: EDELSON LECHTZIN LLP IS INVESTIGATING CLAIMS ON BEHALF OF ARTIVION, INC. CUSTOMERS WHOSE DATA MAY HAVE BEEN COMPROMISED

13-07-2025
NEWTOWN, PA., JULY 13, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF EDELSON LECHTZIN LLP IS INVESTIGATIN...
Více zde

ARTIVION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

03-06-2025
ATLANTA , JUNE 3, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR S...
Více zde

ARTIVION ANNOUNCES CLOSING OF TRANSACTIONS TO EXCHANGE $99.5 MILLION IN PRINCIPAL AMOUNT OF ITS 4.250% CONVERTIBLE NOTES DUE 2025 FOR COMMON STOCK

28-05-2025
ATLANTA , MAY 28, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION ANNOUNCES AGREEMENTS TO EXCHANGE $95 MILLION IN PRINCIPAL AMOUNT OF ITS 4.250% CONVERTIBLE NOTES DUE 2025 FOR COMMON STOCK

14-05-2025
ATLANTA , MAY 14, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

05-05-2025
FIRST QUARTER HIGHLIGHTS: ACHIEVED REVENUE OF $99.0 MILLION IN THE FIRST QUARTER OF 2025 VERSUS $97....
Více zde

ARTIVION ANNOUNCES PRESENTATION OF NEW CLINICAL DATA FROM NEXUS TRIOMPHE IDE TRIAL AT THE 105TH AMERICAN ASSOCIATION FOR THORACIC SURGERY (AATS) ANNUAL MEETING

05-05-2025
30-DAY DATA FROM ENDOSPAN'S NEXUS TRIOMPHE IDE TRIAL DEMONSTRATE 63% REDUCTION IN MAJOR ADVERSE EVEN...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR FIRST QUARTER 2025 FINANCIAL RESULTS

21-04-2025
ATLANTA , APRIL 21, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

ARTIVION TO PARTICIPATE IN THE OPPENHEIMER 35TH ANNUAL HEALTHCARE MEDTECH & SERVICES CONFERENCE

04-03-2025
ATLANTA , MARCH 4, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR...
Více zde

ARTIVION REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

24-02-2025
FOURTH QUARTER HIGHLIGHTS: ACHIEVED REVENUE OF $97.3 MILLION IN THE FOURTH QUARTER OF 2024 VERSUS $9...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

10-02-2025
ATLANTA , FEB. 10, 2025 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION ANNOUNCES PRESENTATION OF LATE-BREAKING DATA FROM AMDS PERSEVERE TRIAL AT THE 61ST SOCIETY OF THORACIC SURGERY ANNUAL MEETING

27-01-2025
FULL IDE DATA SET DEMONSTRATES SUSTAINED BENEFIT AT ONE YEAR WITH USE OF AMDS IN ACUTE DEBAKEY TYPE ...
Více zde

ARTIVION GRANTED FDA HUMANITARIAN DEVICE EXEMPTION FOR THE AMDS HYBRID PROSTHESIS

09-12-2024
ATLANTA , DEC. 9, 2024 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR S...
Více zde

ARTIVION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

07-11-2024
THIRD QUARTER HIGHLIGHTS: ACHIEVED REVENUE OF $95.8 MILLION IN THE THIRD QUARTER OF 2024 VERSUS $87....
Více zde

ARTIVION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

05-11-2024
ATLANTA , NOV. 5, 2024 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION ANNOUNCES RELEASE DATE AND TELECONFERENCE CALL DETAILS FOR THIRD QUARTER 2024 FINANCIAL RESULTS

24-10-2024
ATLANTA , OCT. 24, 2024 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR ...
Více zde

ARTIVION ANNOUNCES PRESENTATION OF LATE-BREAKING CLINICAL DATA AT THE 38TH EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) ANNUAL MEETING

10-10-2024
5-YEAR DATA FROM THE AMDS DARTS TRIAL DEMONSTRATES POSITIVE AORTIC REMODELING WITH 94% OF PATIENTS F...
Více zde

ARTIVION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

08-08-2024
SECOND QUARTER HIGHLIGHTS:  ACHIEVED REVENUE OF $98.0 MILLION IN THE SECOND QUARTER OF 2024 VERSUS ...
Více zde

ARTIVION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

05-08-2024
ATLANTA , AUG. 5, 2024 /PRNEWSWIRE/ -- ARTIVION, INC. (NYSE: AORT), A LEADING CARDIAC AND VASCULAR S...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-12 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-11-06 00:00:008-KStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-09-15 01:00:008-KStáhnout
2025-09-15 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 00:00:008-KStáhnout
2025-05-29 01:00:008-KStáhnout
2025-05-29 00:00:008-KStáhnout
2025-05-16 01:00:008-KStáhnout
2025-05-16 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-05-05 01:00:008-KStáhnout
2025-05-05 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-24 00:00:008-KStáhnout
2025-02-23 23:00:008-KStáhnout
2024-12-23 00:00:008-KStáhnout
2024-12-22 23:00:008-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-08 00:00:0010-QStáhnout
2024-11-07 23:00:0010-QStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-06 23:00:008-KStáhnout
2024-08-09 01:00:0010-QStáhnout
2024-08-09 00:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 00:00:008-KStáhnout
2024-07-01 01:00:008-KStáhnout
2024-07-01 00:00:008-KStáhnout
2024-05-17 01:00:008-KStáhnout
2024-05-17 00:00:008-KStáhnout
2024-05-16 01:00:008-KStáhnout
2024-05-16 00:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 00:00:008-KStáhnout
2024-02-23 00:00:0010-KStáhnout
2024-02-22 23:00:0010-KStáhnout
2024-02-15 00:00:008-KStáhnout
2024-02-14 23:00:008-KStáhnout
2024-01-18 00:00:008-KStáhnout
2024-01-17 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-11-03 00:00:0010-QStáhnout
2023-11-02 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-04 01:00:0010-QStáhnout
2023-08-04 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-05-19 01:00:008-KStáhnout
2023-05-19 00:00:008-KStáhnout
2023-05-05 01:00:0010-QStáhnout
2023-05-05 00:00:0010-QStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-02-16 00:00:008-KStáhnout
2023-02-15 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-04 00:00:0010-QStáhnout
2022-11-03 23:00:0010-QStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-02 23:00:008-KStáhnout
2022-09-29 01:00:008-KStáhnout
2022-09-29 00:00:008-KStáhnout
2022-09-23 01:00:008-KStáhnout
2022-09-23 00:00:008-KStáhnout
2022-08-05 01:00:008-KStáhnout
2022-08-05 01:00:0010-QStáhnout
2022-08-05 00:00:008-KStáhnout
2022-08-05 00:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 00:00:008-KStáhnout
2022-05-20 01:00:008-KStáhnout
2022-05-20 00:00:008-KStáhnout
2022-05-06 01:00:0010-QStáhnout
2022-05-06 00:00:0010-QStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 00:00:008-KStáhnout
2022-02-22 00:00:0010-KStáhnout
2022-02-21 23:00:0010-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-01-20 00:00:008-KStáhnout
2022-01-19 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-11-18 00:00:008-KStáhnout
2021-11-17 23:00:008-KStáhnout
2021-11-05 00:00:0010-QStáhnout
2021-11-04 23:00:0010-QStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-03 23:00:008-KStáhnout
2021-09-22 01:00:008-KStáhnout
2021-09-22 00:00:008-KStáhnout
2021-07-30 01:00:0010-QStáhnout
2021-07-30 00:00:0010-QStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 00:00:008-KStáhnout
2021-06-02 01:00:008-KStáhnout
2021-06-02 00:00:008-KStáhnout
2021-05-25 01:00:008-KStáhnout
2021-05-25 00:00:008-KStáhnout
2021-04-30 01:00:0010-QStáhnout
2021-04-30 00:00:0010-QStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 00:00:008-KStáhnout
2021-03-29 01:00:008-KStáhnout
2021-03-29 00:00:008-KStáhnout
2021-03-23 00:00:008-KStáhnout
2021-03-22 23:00:008-KStáhnout
2021-03-08 00:00:008-KStáhnout
2021-03-07 23:00:008-KStáhnout
2021-02-23 00:00:0010-KStáhnout
2021-02-22 23:00:0010-KStáhnout
2021-02-11 00:00:008-KStáhnout
2021-02-10 23:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-11-04 00:00:008-KStáhnout
2020-11-03 23:00:008-KStáhnout
2020-09-02 01:00:008-KStáhnout
2020-09-02 00:00:008-KStáhnout
2020-07-31 01:00:0010-QStáhnout
2020-07-31 00:00:0010-QStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 00:00:008-KStáhnout
2020-06-23 01:00:008-KStáhnout
2020-06-23 00:00:008-KStáhnout
2020-06-19 01:00:008-KStáhnout
2020-06-19 00:00:008-KStáhnout
2020-06-18 01:00:008-KStáhnout
2020-06-18 00:00:008-KStáhnout
2020-05-22 01:00:008-KStáhnout
2020-05-22 00:00:008-KStáhnout
2020-05-01 01:00:0010-QStáhnout
2020-05-01 00:00:0010-QStáhnout
2020-04-30 01:00:008-KStáhnout
2020-04-30 00:00:008-KStáhnout
2020-04-01 01:00:008-KStáhnout
2020-04-01 00:00:008-KStáhnout
2020-02-19 00:00:0010-KStáhnout
2020-02-18 23:00:0010-KStáhnout
2020-02-13 00:00:008-KStáhnout
2020-02-12 23:00:008-KStáhnout
2019-10-31 00:00:0010-QStáhnout
2019-10-30 23:00:0010-QStáhnout
2019-10-30 00:00:008-KStáhnout
2019-10-29 23:00:008-KStáhnout
2019-09-11 01:00:008-KStáhnout
2019-09-11 00:00:008-KStáhnout
2019-07-31 01:00:0010-QStáhnout
2019-07-31 00:00:0010-QStáhnout
2019-07-30 01:00:008-KStáhnout
2019-07-30 00:00:008-KStáhnout
2019-05-17 01:00:008-KStáhnout
2019-05-17 00:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-04-30 01:00:008-KStáhnout
2019-04-30 00:00:008-KStáhnout
2019-04-01 01:00:008-KStáhnout
2019-04-01 00:00:008-KStáhnout
2019-02-26 00:00:008-KStáhnout
2019-02-26 00:00:0010-KStáhnout
2019-02-25 23:00:008-KStáhnout
2019-02-25 23:00:0010-KStáhnout
2019-02-14 00:00:008-KStáhnout
2019-02-13 23:00:008-KStáhnout
2018-11-01 00:00:008-KStáhnout
2018-11-01 00:00:0010-QStáhnout
2018-10-31 23:00:008-KStáhnout
2018-10-31 23:00:0010-QStáhnout
2018-10-31 00:00:008-KStáhnout
2018-10-30 23:00:008-KStáhnout
2018-10-16 01:00:008-KStáhnout
2018-10-16 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-06-20 01:00:008-KStáhnout
2018-06-20 00:00:008-KStáhnout
2018-05-25 01:00:008-KStáhnout
2018-05-25 00:00:008-KStáhnout
2018-05-04 01:00:0010-QStáhnout
2018-05-04 00:00:0010-QStáhnout
2018-05-03 01:00:008-KStáhnout
2018-05-03 00:00:008-KStáhnout
2018-03-14 00:00:008-KStáhnout
2018-03-13 23:00:008-KStáhnout
2018-03-09 00:00:0010-KStáhnout
2018-03-08 23:00:0010-KStáhnout
2018-03-08 00:00:008-KStáhnout
2018-03-07 23:00:008-KStáhnout
2018-02-22 00:00:008-KStáhnout
2018-02-21 23:00:008-KStáhnout
2018-02-12 00:00:008-KStáhnout
2018-02-11 23:00:008-KStáhnout
2018-01-31 00:00:008-KStáhnout
2018-01-30 23:00:008-KStáhnout
2017-12-01 00:00:008-KStáhnout
2017-11-30 23:00:008-KStáhnout
2017-10-31 00:00:008-KStáhnout
2017-10-31 00:00:0010-QStáhnout
2017-10-30 23:00:008-KStáhnout
2017-10-30 23:00:0010-QStáhnout
2017-10-11 01:00:008-KStáhnout
2017-10-11 00:00:008-KStáhnout
2017-10-02 01:00:008-KStáhnout
2017-10-02 00:00:008-KStáhnout
2017-09-07 01:00:008-KStáhnout
2017-09-07 00:00:008-KStáhnout
2017-07-25 01:00:008-KStáhnout
2017-07-25 01:00:0010-QStáhnout
2017-07-25 00:00:008-KStáhnout
2017-07-25 00:00:0010-QStáhnout
2017-05-23 01:00:008-KStáhnout
2017-05-23 00:00:008-KStáhnout
2017-04-27 01:00:008-KStáhnout
2017-04-27 01:00:0010-QStáhnout
2017-04-27 00:00:008-KStáhnout
2017-04-27 00:00:0010-QStáhnout
2017-03-23 00:00:008-KStáhnout
2017-03-22 23:00:008-KStáhnout
2017-03-16 00:00:008-KStáhnout
2017-03-15 23:00:008-KStáhnout
2017-02-21 00:00:008-KStáhnout
2017-02-20 23:00:008-KStáhnout
2017-02-16 00:00:008-KStáhnout
2017-02-16 00:00:0010-KStáhnout
2017-02-15 23:00:008-KStáhnout
2017-02-15 23:00:0010-KStáhnout
2016-11-22 00:00:008-KStáhnout
2016-11-21 23:00:008-KStáhnout
2016-10-27 01:00:008-KStáhnout
2016-10-27 01:00:0010-QStáhnout
2016-10-27 00:00:008-KStáhnout
2016-10-27 00:00:0010-QStáhnout
2016-07-26 01:00:008-KStáhnout
2016-07-26 01:00:0010-QStáhnout
2016-07-26 00:00:008-KStáhnout
2016-07-26 00:00:0010-QStáhnout
2016-05-23 01:00:008-KStáhnout
2016-05-23 00:00:008-KStáhnout
2016-04-29 01:00:0010-QStáhnout
2016-04-29 00:00:0010-QStáhnout
2016-04-28 01:00:008-KStáhnout
2016-04-28 00:00:008-KStáhnout
2016-04-14 01:00:008-KStáhnout
2016-04-14 00:00:008-KStáhnout
2016-03-18 00:00:008-KStáhnout
2016-03-17 23:00:008-KStáhnout
2016-03-01 00:00:008-KStáhnout
2016-02-29 23:00:008-KStáhnout
2016-02-16 00:00:008-KStáhnout
2016-02-16 00:00:0010-KStáhnout
2016-02-15 23:00:008-KStáhnout
2016-02-15 23:00:0010-KStáhnout
2016-02-08 00:00:008-KStáhnout
2016-02-07 23:00:008-KStáhnout
2016-01-25 00:00:008-KStáhnout
2016-01-24 23:00:008-KStáhnout
2015-12-23 00:00:008-KStáhnout
2015-12-22 23:00:008-KStáhnout
2015-11-23 00:00:008-KStáhnout
2015-11-22 23:00:008-KStáhnout
2015-11-17 00:00:008-KStáhnout
2015-11-16 23:00:008-KStáhnout
2015-10-27 00:00:008-KStáhnout
2015-10-27 00:00:0010-QStáhnout
2015-10-26 23:00:008-KStáhnout
2015-10-26 23:00:0010-QStáhnout
2015-10-13 01:00:008-KStáhnout
2015-10-13 00:00:008-KStáhnout
2015-10-09 01:00:008-KStáhnout
2015-10-09 00:00:008-KStáhnout
2015-09-09 01:00:008-KStáhnout
2015-09-09 00:00:008-KStáhnout
2015-07-28 01:00:008-KStáhnout
2015-07-28 01:00:0010-QStáhnout
2015-07-28 00:00:008-KStáhnout
2015-07-28 00:00:0010-QStáhnout
2015-05-26 01:00:008-KStáhnout
2015-05-26 00:00:008-KStáhnout
2015-04-29 01:00:0010-QStáhnout
2015-04-29 00:00:0010-QStáhnout
2015-04-28 01:00:008-KStáhnout
2015-04-28 00:00:008-KStáhnout
2015-04-27 01:00:008-KStáhnout
2015-04-27 00:00:008-KStáhnout
2015-04-10 01:00:008-KStáhnout
2015-04-10 00:00:008-KStáhnout
2015-02-18 00:00:008-KStáhnout
2015-02-17 23:00:008-KStáhnout
2015-02-17 00:00:008-KStáhnout
2015-02-17 00:00:0010-KStáhnout
2015-02-16 23:00:008-KStáhnout
2015-02-16 23:00:0010-KStáhnout
2014-12-30 00:00:008-KStáhnout
2014-12-29 23:00:008-KStáhnout
2014-10-28 00:00:008-KStáhnout
2014-10-28 00:00:0010-QStáhnout
2014-10-27 23:00:008-KStáhnout
2014-10-27 23:00:0010-QStáhnout
2014-10-27 00:00:008-KStáhnout
2014-10-26 23:00:008-KStáhnout
2014-10-24 01:00:008-KStáhnout
2014-10-24 00:00:008-KStáhnout
2014-10-01 01:00:008-KStáhnout
2014-10-01 00:00:008-KStáhnout
2014-09-09 01:00:008-KStáhnout
2014-09-09 00:00:008-KStáhnout
2014-09-02 01:00:008-KStáhnout
2014-09-02 00:00:008-KStáhnout
2014-08-22 01:00:008-KStáhnout
2014-08-22 00:00:008-KStáhnout
2014-07-24 01:00:008-KStáhnout
2014-07-24 01:00:0010-QStáhnout
2014-07-24 00:00:008-KStáhnout
2014-07-11 01:00:008-KStáhnout
2014-07-11 00:00:008-KStáhnout
2014-05-27 01:00:008-KStáhnout
2014-05-27 00:00:008-KStáhnout
2014-04-30 01:00:0010-QStáhnout
2014-04-30 00:00:0010-QStáhnout
2014-04-29 01:00:008-KStáhnout
2014-04-29 00:00:008-KStáhnout
2014-04-08 01:00:008-KStáhnout
2014-04-08 00:00:008-KStáhnout
2014-03-31 01:00:008-KStáhnout
2014-03-31 00:00:008-KStáhnout
preloader